Exploration of Human Serum Albumin Binding Sites by Docking and Molecular Dynamics Flexible Ligand-Protein Interactions

被引:80
作者
Deeb, Omar [3 ]
Cecilia Rosales-Hernandez, Martha [1 ,2 ]
Gomez-Castro, Carlos [1 ,2 ]
Garduno-Juarez, Ramon [4 ]
Correa-Basurto, Jose [1 ,2 ]
机构
[1] Inst Politecn Nacl, Lab Modelado Mol SEPI, Mexico City 11340, DF, Mexico
[2] Inst Politecn Nacl, Escuela Super Med, Dept Bioquim, Mexico City 11340, DF, Mexico
[3] Al Quds Univ, Fac Pharm, Jerusalem, Israel
[4] Univ Nacl Autonoma Mexico, Inst Ciencias Fis, Cuernavaca 62250, Morelos, Mexico
关键词
human serum albumin; molecular dynamics; docking; multiple linear regression analysis; DRUG-DESIGN; CONFORMATIONAL-CHANGE; SIMULATIONS; FLEXIBILITY; PREDICTION; COMPLEXES; MODELS; DOMAIN; PROMISCUITY; INTEGRATION;
D O I
10.1002/bip.21314
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Five-nanosecond molecular dynamics (MD) simulations were performed on human serum albumin (HSA) to study the conformational features of its primary ligand binding sites (I and II). Additionally, II HSA snapshots were extracted every 0.5 ns to explore the binding affinity (K-d) of 94 known HSA binding drugs using a blind docking procedure. MD simulations indicate that there is considerable flexibility for the protein, including the known sites I and II. Movements at HSA sites I and II were evidenced by structural analyses and docking simulations. The latter enabled the study and analysis of the HSA-ligand interactions of warfarin and ketoprofen (ligands binding to sites I and II, respectively) in greater detail. Our results indicate that the free energy values by docking (Kd observed) depend upon the conformations of both HSA and the ligand. The 94 HSA-ligand binding Kd values, obtained by the docking procedure, were subjected to a quantitative structure-activity relationship (QSAR) study by multiple regression analysis. The best correlation between the observed and QSAR theoretical (K-d predicted) data was displayed at 2.5 ns. This study provides evidence that HSA binding sites I and II interact specifically with a variety of compounds through conformational adjustments of the protein structure in conjunction with ligand conformational adaptation to these sites. These results serve to explain the high ligand-promiscuity of HSA. (C) 2009 Wiley Periodicals, Inc. Biopolymers 93: 161-170, 2010.
引用
收藏
页码:161 / 170
页数:10
相关论文
共 55 条
[1]
Combining docking and molecular dynamic simulations in drug design [J].
Alonso, Hernan ;
Bliznyuk, Andrey A. ;
Gready, Jill E. .
MEDICINAL RESEARCH REVIEWS, 2006, 26 (05) :531-568
[2]
Molecular dynamics simulations of the ligand-binding domain of the ionotropic glutamate receptor GluR2 [J].
Arinaminpathy, Y ;
Sansom, MSP ;
Biggin, PC .
BIOPHYSICAL JOURNAL, 2002, 82 (02) :676-683
[3]
Artali Roberto, 2005, Farmaco (Lausanne), V60, P485, DOI 10.1016/j.farmac.2005.04.010
[4]
Ligand recognition by chloroperoxidase using molecular interaction fields and quantum chemistry calculations [J].
-Basurto, J. C. ;
Aburto, J. ;
-Ferrara, J. T. ;
Torres, E. .
MOLECULAR SIMULATION, 2007, 33 (08) :649-654
[5]
Optimized particle-mesh Ewald/multiple-time step integration for molecular dynamics simulations [J].
Batcho, PF ;
Case, DA ;
Schlick, T .
JOURNAL OF CHEMICAL PHYSICS, 2001, 115 (09) :4003-4018
[6]
Use of an immobilised human serum albumin HPLC column as a probe of drug-protein interactions: the reversible binding of valproate [J].
Bertucci, C ;
Andrisano, V ;
Gotti, R ;
Cavrini, V .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 768 (01) :147-155
[7]
Carlson HA, 2000, MOL PHARMACOL, V57, P213
[8]
Cheminformatic models to predict binding affinities to human serum albumin [J].
Colmenarejo, G ;
Alvarez-Pedraglio, A ;
Lavandera, JL .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (25) :4370-4378
[9]
Docking and quantum mechanic studies on cholinesterases and their inhibitors [J].
Correa-Basurto, Jose ;
Flores-Sandoval, Cesar ;
Marin-Cruz, Jesus ;
Rojo-Dominguez, Arturo ;
Espinoza-Fonseca, L. Michel ;
Trujillo-Ferrara, Jose G. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2007, 42 (01) :10-19
[10]
Induced disorder in protein-ligand complexes as a drug-design strategy [J].
Crespo, Alejandro ;
Fernandez, Ariel .
MOLECULAR PHARMACEUTICS, 2008, 5 (03) :430-437